MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $17,626,000 | -6.9% | 4,247,163 | -6.2% | 0.02% | -10.5% |
Q1 2019 | $18,924,000 | +44.8% | 4,527,325 | -0.6% | 0.02% | +26.7% |
Q4 2018 | $13,072,000 | -31.3% | 4,554,759 | +139.4% | 0.02% | -16.7% |
Q3 2018 | $19,025,000 | -2.4% | 1,902,523 | -31.0% | 0.02% | -5.3% |
Q2 2018 | $19,495,000 | +86.6% | 2,757,356 | +0.8% | 0.02% | +90.0% |
Q1 2018 | $10,450,000 | -52.5% | 2,735,623 | +1.4% | 0.01% | -54.5% |
Q4 2017 | $22,004,000 | +133.3% | 2,696,553 | +67.8% | 0.02% | +120.0% |
Q3 2017 | $9,432,000 | +748.2% | 1,606,733 | +98.0% | 0.01% | +900.0% |
Q2 2017 | $1,112,000 | +61.2% | 811,665 | +108.1% | 0.00% | 0.0% |
Q1 2017 | $690,000 | – | 390,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |